跳至主要内容
临床试验/JPRN-UMIN000037931
JPRN-UMIN000037931已完成未知

Clinical evaluation of irAEs in ptients with ICI - Clinical evaluation of irAEs in ptients with ICI

Toho University School of Medicine0 个研究点目标入组 88 人开始时间: 2019年9月9日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
88

研究概览

简要总结

Compared to the non-diabetes, diabetes has not been associated with irAEs risks for baseline characteristics and after propensity score matching analysis. During a mean follow-up of 30 months, overall (OS) and cancer specific progression free survival (PFS) were significantly improved in irAEs group. After propensity scores analyses, DM was significantly associated with increased risks of lower OS.

研究设计

研究类型
Observational

入排标准

年龄范围
47years-old 至 79years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 未提供

研究者

发起方
Toho University School of Medicine

相似试验

已完成
不适用
iraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results Trial in JapaACS patient with type II diabetes
JPRN-UMIN000006817Department of Cardiovascular Medicine, Saga University20
已完成
不适用
ipids in Diabetes StudyType 2 diabetesNutritional, Metabolic, EndocrineDiabetes
ISRCTN22144829Bayer PLC (UK)5,000
进行中(未招募)
不适用
iraglutide Effect and Action in Diabetes (LEAD-1): Effect on glycaemic control after once daily administration of liraglutide in combination with glimepiride versus glimepiride monotherapy versus glimepiride and rosiglitazone combination therapy in subjects with type 2 diabetesA six-month double-blind, double-dummy, randomised, active control, parallel-group, multi-centre, multi-national trialMedDRA version: 8,0Level: PTClassification code 10012601Diabetes Mellitus
EUCTR2005-003414-15-FIovo Nordisk A/S1,865
进行中(未招募)
不适用
iraglutide Effect and Action in Diabetes (LEAD-1): Effect on glycaemic control after once daily administration of liraglutide in combination with glimepiride versus glimepiride monotherapy versus glimepiride and rosiglitazone combination therapy in subjects with type 2 diabetesA six-month double-blind, double-dummy, randomised, active control, parallel-group, multi-centre, multi-national trialMedDRA version: 8,0Level: PTClassification code 10012601Diabetes Mellitus
EUCTR2005-003414-15-CZovo Nordisk A/S1,865
招募中
不适用
Effect of intensive insulin therapy on diabetic retinopathy and other diabetic complicationsdiabetes mellitus
JPRN-UMIN000026379Aichi Medical University department of ophthalmology150